Areas in which we strive to advance treatment

At Ferring we have a focus in the development of new medicines, however three areas of interest are key in our aspiration to improve conditions for patients all over the world. We have the world’s largest portfolio of peptide-based medicine but also excel in recombinant protein and biological therapeutics. Additionally, we are dedicated to improving methods of delivery, to make medicine as patient-friendly as possible.